...
首页> 外文期刊>Current pain and headache reports. >Treatment of perimenstrual migraine with triptans: an update.
【24h】

Treatment of perimenstrual migraine with triptans: an update.

机译:曲坦类药物治疗经期偏头痛的最新进展。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Pure menstrual migraine (PMM) and menstrually related migraine (MRM) are difficult challenges in migraine management. Triptans are a class of highly selective serotonin receptor agonists, which interfere with the pathogenesis of migraine and are effective in relieving the associated neurovegetative symptoms. In recent years triptans have been extensively proposed for the treatment of severe, disabling, and recurrent perimenstrual migraine attacks. This review summarizes the different levels of recommendations for the use of triptans in the treatment of perimenstrual migraine. This review is also intended to offer an updated reasonable guide to physicians treating perimenstrual migraine in daily practice.
机译:纯月经偏头痛(PMM)和月经相关性偏头痛(MRM)是偏头痛治疗中的难题。 Triptans是一类高度选择性的血清素受体激动剂,可干扰偏头痛的发病机理,并有效缓解相关的神经营养症状。近年来,曲坦类药物已被广泛提议用于治疗严重,致残和反复发作的经期偏头痛。这篇综述总结了使用曲普坦治疗经期偏头痛的不同建议水平。这篇综述还旨在为医生在日常实践中治疗经期偏头痛提供最新的合理指导。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号